Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Life Sciences
|
October 2, 2023
Corrigendum to "NEAT1: Culprit lncRNA linking PIGC, MSLN, and CD80 in triple-negative breast cancer" [Life Sci., volume 299 (2022) 120523]
Nada H Hussein, Monica Armanious, Reda A Eissa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 17, 1978
On the calibration of automated enzymatic cholesterol determinations
A M de Bruyn, F Klein, C M van Gent, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
January 1, 1993
Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study
M L Bots, A Hofman, A M de Bruyn, et al.
Journal of Forensic Sciences
|
December 1, 2004
Trace analysis of peroxide explosives by high performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry (HPLC-APCI-MS/MS) for forensic applications
Xiaoma Xu, Anick M van de Craats, Eric M Kok, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 22, 1980
Serum IgM in primary biliary cirrhosis
B G Taal, S W Schalm, A M de Bruyn, et al.
Journal of Immunological Methods
|
January 1, 1982
The absolute quantification of human IgM and IgG: standardization and normal values
A M De Bruyn, F Klein, H Neumann, et al.
Sleep
|
January 1, 1982
Daytime sleepiness in patients with periodic movements in sleep
R M Coleman, D L Bliwise, N Sajben, et al.
The Journal of Biological Chemistry
|
May 28, 1998
Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB
P C van Weeren, K M de Bruyn, A M de Vries-Smits, et al.
Cancer Treatment Reviews
|
July 19, 2024
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act
J F Tiersma, B Evers, B M Bakker, et al.
Leukemia
|
March 6, 2009
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
B ten Cate, E Bremer, M de Bruyn, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Life Sciences
|
October 2, 2023
Corrigendum to "NEAT1: Culprit lncRNA linking PIGC, MSLN, and CD80 in triple-negative breast cancer" [Life Sci., volume 299 (2022) 120523]
Nada H Hussein, Monica Armanious, Reda A Eissa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 17, 1978
On the calibration of automated enzymatic cholesterol determinations
A M de Bruyn, F Klein, C M van Gent, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
January 1, 1993
Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study
M L Bots, A Hofman, A M de Bruyn, et al.
Journal of Forensic Sciences
|
December 1, 2004
Trace analysis of peroxide explosives by high performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry (HPLC-APCI-MS/MS) for forensic applications
Xiaoma Xu, Anick M van de Craats, Eric M Kok, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 22, 1980
Serum IgM in primary biliary cirrhosis
B G Taal, S W Schalm, A M de Bruyn, et al.
Journal of Immunological Methods
|
January 1, 1982
The absolute quantification of human IgM and IgG: standardization and normal values
A M De Bruyn, F Klein, H Neumann, et al.
Sleep
|
January 1, 1982
Daytime sleepiness in patients with periodic movements in sleep
R M Coleman, D L Bliwise, N Sajben, et al.
The Journal of Biological Chemistry
|
May 28, 1998
Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB
P C van Weeren, K M de Bruyn, A M de Vries-Smits, et al.
Cancer Treatment Reviews
|
July 19, 2024
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act
J F Tiersma, B Evers, B M Bakker, et al.
Leukemia
|
March 6, 2009
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
B ten Cate, E Bremer, M de Bruyn, et al.
Page
of 6